Elevance Health, Inc. (ELV)
| Market Cap | 86.88B |
| Revenue (ttm) | 183.12B |
| Net Income (ttm) | 5.92B |
| Shares Out | 225.93M |
| EPS (ttm) | 25.60 |
| PE Ratio | 15.02 |
| Forward PE | 10.87 |
| Dividend | $6.84 (1.78%) |
| Ex-Dividend Date | Jun 10, 2025 |
| Volume | 958,521 |
| Open | 383.83 |
| Previous Close | 386.22 |
| Day's Range | 382.41 - 388.16 |
| 52-Week Range | 357.45 - 567.26 |
| Beta | 0.62 |
| Analysts | Buy |
| Price Target | 508.10 (+32.13%) |
| Earnings Date | Jul 16, 2025 |
About ELV
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, a... [Read more]
Financial Performance
In 2024, Elevance Health's revenue was $176.81 billion, an increase of 3.19% compared to the previous year's $171.34 billion. Earnings were $5.98 billion, a decrease of -0.12%.
Financial StatementsAnalyst Forecast
According to 14 analysts, the average rating for ELV stock is "Buy." The 12-month stock price forecast is $508.1, which is an increase of 32.13% from the latest price.
News
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Elevance To Contact Him Directly To Discuss Their Options
The Highest-Quality Dividend Contenders By Quality Scores
The article presents the highest-quality Dividend Contenders, companies listed on U.S. exchanges with higher annual dividend payouts for 10-24 consecutive years. I use a quality scoring system with si...
ELV LEGAL NOTICE: Lose Money when Elevance Health, Inc. Stock Plummeted 11%? Contact BFA Law by the July 11 Court Deadline (NYSE:ELV)
NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE: ELV) and certain of the ...
ELV Shareholders Have the Right to Lead the Elevance Health, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELV
LOS ANGELES , June 9, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Elevance Health, Inc. ("Elevance" or "the Company") (NYSE: ELV) for violations of the f...
ELV INVESTOR NEWS: Elevance Health, Inc. has been Sued for Securities Fraud – Contact BFA Law before July 11 Deadline (NYSE:ELV)
NEW YORK, June 08, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE: ELV) and certain of the ...
ELV LAWSUIT: Elevance Health, Inc. Lawsuit Alleges Securities Fraud Violations - Investors Notified to Contact BFA Law
NEW YORK, NY / ACCESS Newswire / June 4, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE:ELV) and certain of t...
ELV STOCK NOTICE: Elevance Health, Inc. has been Sued for Fraud; Investors are Notified to Contact BFA Law before July 11 Legal Deadline
NEW YORK CITY, NY / ACCESS Newswire / June 3, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE:ELV) and certain...
20 stocks primed for rapid growth while trading at half of Nvidia's valuation
When selecting investments, it is easy to get hung up on a particular metric, such as a dividend yield or a price ratio, but investors need to look deeper or they might miss opportunities.
ELV CLASS NOTICE: Elevance Health, Inc. Investors may have been Affected by Fraud – Contact BFA Law before July 11 Court Deadline (NYSE:ELV)
NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE: ELV) and certain of the C...
Elevance Health: A Bargain At 11x Earnings
Elevance Health is undervalued after a 27% drop, trading at the low end of its historical P/E range with significant upside potential. Managed care organizations like Elevance benefit from scale, stro...
ELV FRAUD: Suffer Losses on Elevance Health, Inc.? You may have been Affected by Fraud and are Urged to Contact BFA Law (NYSE:ELV)
NEW YORK, May 25, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE: ELV) and certain of the C...
ELV FRAUD NEWS: Elevance Health, Inc. is Being Sued for Securities Fraud; Investors That Lost Money Are Urged to Contact BFA Law by July 11 Court Deadline
NEW YORK CITY, NY / ACCESS Newswire / May 23, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE:ELV) and certain...
ELV LAWSUIT: Lose Money on Elevance Health, Inc.? Contact BFA Law before July 11 Court Deadline
NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE: ELV) and certain of the C...
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Elevance Health, Inc. (ELV)
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of In...
Verily CEO tells staff the sale of its insurance business is a 'strategic win' as the deal closes
Elevance Health's acquisition of Verily's insurance business has closed. Verily's CEO told staff in a memo that the sale will strengthen the company's financial position.
10 Undervalued Dividend Growth Stocks: May 2025
I rank a selection of undervalued dividend growth stocks in Dividend Radar and present the top ten stocks for consideration. I use two valuation screens, one based on my fair value estimate, and anoth...
DOJ Files Complaint Against Aetna, eHealth, Others, Alleging Medicare Advantage Kickbacks
The DOJ alleges in its complaint that CVS Health-unit Aetna, Elevance Health and Humana paid the kickbacks to brokers eHealth, GoHealth and SelectQuote in exchange for enrollments into the insurers' M...
Elevance Health: Carelon Growth Not Fully Appreciated
Elevance Health, Inc.'s Q1 results showed stable Medicare utilization and reaffirmed guidance, in contrast to sector volatility following UnitedHealth Group's rough earnings miss. Medicaid pressures r...
Elevance Health, Inc. (ELV) Q1 2025 Earnings Call Transcript
Elevance Health, Inc. (NYSE:ELV) Q1 2025 Earnings Conference Call April 22, 2025 8:30 AM ET Company Participants Nathan Rich - VP, IR Gail Boudreaux - President & CEO Mark Kaye - CFO Felicia Norwood ...
Elevance confirms quarterly profit beat, reaffirms 2025 forecast
Health insurer Elevance Health said on Tuesday its first-quarter profit came above Street expectations, matching the preliminary estimates it released last week after bellwether UnitedHealth's lowered...
Elevance Health Reports First Quarter 2025 Results
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported first quarter 2025 results. “At Elevance Health, our purpose—to improve the health of humanity—drives everything we do. In the...
Health insurer Elevance sees first-quarter profit above estimates
Elevance Health said on Thursday it expects first-quarter profit above estimates, helped by medical cost trends that were in line with its expectations.
Elevance Health: A Hidden Gem Amongst Healthcare Turbulence
Elevance Health's resilience in a volatile health insurance market is driven by its fee-based Commercial plans and preventive care initiatives. The company's focus on administrative services only plan...
Which Stocks Stayed Green as the Market Plummeted?
Only a handful of S&P 500 stocks managed to generate gains during the market's historic four-day plunge.
GreensKeeper Q1 2025 Portfolio Update
Berkshire Hathaway led Q1 with a 17.5% return, driven by strong operating earnings and potential for significant acquisitions with over $300 billion in cash. Vertex Pharmaceuticals gained 20.4%, fuele...